UNFO Med is the developer of the Universal Neonatal Foot Orthotics (UNFO) device, a child-friendly corrective foot brace developed specifically for the effective, safe, and stress-free treatment of metatarsus adductus (MTA) in newborns. The UNFO brace addresses the difficulties and stress of frequent casting, the ineffectiveness of stretching, and the resulting under-treatment or over-treatment of MTA and clubfoot. UNFO has clients in Israel, Italy, Africa, Ukraine, and South Korea, and has received FDA approval in the United States and CE mark approval in Europe.